AS
Ascentage Pharma Group International
ASPHF · OTC
$4.53 +0.00% (+$0.00)
Market Cap ¥11.3B
P/E Ratio -
Div. Yield -
ROE 172.24%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 8.55x
P/S 20.27x
PEG N/A
Growth
100 /100
Growing Book val. growth 48.01%
Rev. growth 38.68%
FCF growth N/A
Profitability
20 /100
Weak FCF margin 214.86%
Op. margin 211.14%
Gross margin 76.41%
Quality
2 /100
Poor Asset turnover 0.14x
ROA 30.53%
ROIC 33.50%
Debt
37 /100
Moderate Current ratio 1.79x
Int. coverage -22.42x
Debt/Equity 1.49x
Stability
26 /100
Unstable Profitable years 0
EPS volatility 107.94%
Beta 0.66x
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o ASPHF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dajun Yang
Employees
767
Headquarters
Suzhou
Nadchodzące wydarzenia
31 MAR
Earnings
Upcoming earnings report